Dollar climbs to the highs for the day against the euro, pound, franc
As mentioned, just be mindful that there is some expectation that we may see stronger numbers than anticipated – on top of the already strong estimates. So, there is a slight propensity to expect an upside surprise to the report later.

A bit of a quiet one in Europe once again
Major currencies aren’t doing a whole lot, with the dollar holding a tad mixed as it sits lower against the yen (which is helped by lower yields) while commodity currencies are extending gains on the week amid the more buoyed risk sentiment.

Shanghai Securities News reports on the matter
Central banks across the globe have mitigated credit risks rather well during this unprecedented time but in China, worries are starting to surface again amid the whole Huarong debacle over the past two weeks or so.

10-year yields down 1.7 bps to 1.615%
Aside from some modest strength in commodity currencies, owing to firmer risk sentiment, not much else is happening as the market counts down to the US retail sales report later.

EU to receive 50 million doses of Pfizer vaccine earlier in Q2 rather than in Q4 as scheduled initially
That is a welcome boost for the vaccine rollout as EU president von der Leyen touts a milestone achievement for the bloc as they reach 100 million vaccinations. Things are starting to pick up now in the

Goldman Sachs reports strong earnings after JP Morgan

Latest data from the Mortgage Bankers Association for the week ending 9 April 2021
–  -5.1%
– Market index 667.7 vs 693.5 prior
– Refinancing index 2,916.7 vs 3,068.8 prior

JP Morgan earnings crushes the consensus
The firm’s trading desks had a great showing and soaring investment banking fees adds to the more upbeat results across the board. JPM CEO, Jamie Dimon, reflects on that in saying there is a „strong underlying performance across our businesses“.

EU budget commissioner, Johannes Hahn, says in a statement

Stock futures fall on the announcement
This being reported by the New York Times, as the FDA and CDC call for a pause in the Johnson & Johnson vaccine after six recipients were said to develop a rare disorder involving blood clots within about two weeks of the vaccination. More .